Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Cancer Treatment and Research
|
June 16, 2015
Preface
Chad A Mirkin, Thomas A Meade, Sarah Hurst Petrosko, et al.
Cancer Treatment and Research
|
April 22, 2015
Therapeutic applications of spherical nucleic acids
Stacey N Barnaby, Timothy L Sita, Sarah Hurst Petrosko, et al.
The Journal of Clinical Investigation
|
July 1, 2026
Therapeutic targeting of the cGAS-STING pathway in human disease
Akanksha S Mahajan, Connor M Forsyth, Cao Dai Phung, et al.
Science Advances
|
May 28, 2019
Cancer-associated mutation and beyond: The emerging biology of isocitrate dehydrogenases in human disease
Serena Tommasini-Ghelfi, Kevin Murnan, Fotini M Kouri, et al.
The Journal of Cell Biology
|
September 18, 2002
DEDD regulates degradation of intermediate filaments during apoptosis
Justine C Lee, Olaf Schickling, Alexander H Stegh, et al.
The Journal of Biological Chemistry
|
December 26, 2001
Inactivation of caspase-8 on mitochondria of Bcl-xL-expressing MCF7-Fas cells: role for the bifunctional apoptosis regulator protein
Alexander H Stegh, Bryan C Barnhart, Jorg Volkland, et al.
Journal of the American Chemical Society
|
August 15, 2015
Ribozyme-Spherical Nucleic Acids
Jessica L Rouge, Timothy L Sita, Liangliang Hao, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 2, 2008
Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma
Alexander H Stegh, Santosh Kesari, John E Mahoney, et al.
Genes & Development
|
September 15, 2010
Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor
Alexander H Stegh, Cameron Brennan, John A Mahoney, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 8, 2014
Bcl2L13 is a ceramide synthase inhibitor in glioblastoma
Samuel A Jensen, Andrea E Calvert, Giora Volpert, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Cancer Treatment and Research
|
June 16, 2015
Preface
Chad A Mirkin, Thomas A Meade, Sarah Hurst Petrosko, et al.
Cancer Treatment and Research
|
April 22, 2015
Therapeutic applications of spherical nucleic acids
Stacey N Barnaby, Timothy L Sita, Sarah Hurst Petrosko, et al.
The Journal of Clinical Investigation
|
July 1, 2026
Therapeutic targeting of the cGAS-STING pathway in human disease
Akanksha S Mahajan, Connor M Forsyth, Cao Dai Phung, et al.
Science Advances
|
May 28, 2019
Cancer-associated mutation and beyond: The emerging biology of isocitrate dehydrogenases in human disease
Serena Tommasini-Ghelfi, Kevin Murnan, Fotini M Kouri, et al.
The Journal of Cell Biology
|
September 18, 2002
DEDD regulates degradation of intermediate filaments during apoptosis
Justine C Lee, Olaf Schickling, Alexander H Stegh, et al.
The Journal of Biological Chemistry
|
December 26, 2001
Inactivation of caspase-8 on mitochondria of Bcl-xL-expressing MCF7-Fas cells: role for the bifunctional apoptosis regulator protein
Alexander H Stegh, Bryan C Barnhart, Jorg Volkland, et al.
Journal of the American Chemical Society
|
August 15, 2015
Ribozyme-Spherical Nucleic Acids
Jessica L Rouge, Timothy L Sita, Liangliang Hao, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 2, 2008
Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma
Alexander H Stegh, Santosh Kesari, John E Mahoney, et al.
Genes & Development
|
September 15, 2010
Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor
Alexander H Stegh, Cameron Brennan, John A Mahoney, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 8, 2014
Bcl2L13 is a ceramide synthase inhibitor in glioblastoma
Samuel A Jensen, Andrea E Calvert, Giora Volpert, et al.
Page
of 5